Emergence of a unique group of necrotizing mycobacterial diseases. by Dobos, K. M. et al.
367 Vol. 5, No. 3, MayJune 1999 Emerging Infectious Diseases
Synopses
Emergence of a Unique Group of
Necrotizing Mycobacterial Diseases
Karen M. Dobos,* Frederick D. Quinn, David A. Ashford,
C. Robert Horsburgh,* and C. Harold King*
*Emory University School of Medicine, Atlanta, Georgia, USA; Centers for
Disease Control and Prevention, Atlanta, Georgia, USA
Address for correspondence: C. Harold King, Division of
Infectious Diseases, Department of Medicine, Emory
University School of Medicine, 69 Butler Street SE, Atlanta,
GA 30303; fax: 404-880-9305; e-mail: cking01@emory.edu.
Diseases Caused by Emergence of
Atypical Mycobacteria
Mycobacterial diseases cause substantial
illness and death throughout the world, despite
years of public health control efforts. Although
most illnesses and deaths are due to tuberculosis
(1), particularly in developing countries and in
association with the AIDS pandemic (2), diseases
caused by nontuberculous mycobacteria (NTM)
have had a strong impact on human populations
in both developing and industrialized countries
(3). Many NTM diseases, such as those caused by
Mycobacterium avium complex, are considered
opportunistic infections in patients with AIDS
(4). However, the rates of non-AIDS-associated
NTM infections are also increasing (5). Specifically,
disease caused by M. ulcerans, M. marinum, and
M. haemophilum has increased in both healthy
and immunocompromised patients in the last
decade. Moreover, these diseases have been
reported from previously unaffected geographic
areas, which indicates an increase in the
geographic distribution of these organisms.
Of these three emerging NTM diseases,
Buruli ulcer (BU), caused by M. ulcerans, poses
the greatest immediate public health threat.
Although most diseases due to pathogenic mycobacteria are caused by
Mycobacterium tuberculosis, several other mycobacterial diseases—caused by M.
ulcerans  (Buruli ulcer), M. marinum, and M. haemophilum—have begun to emerge. We
review the emergence of diseases caused by these three pathogens in the United
States and around the world in the last decade. We examine the pathophysiologic
similarities of the diseases (all three cause necrotizing skin lesions) and common
reservoirs of infection (stagnant or slow-flowing water). Examination of the histologic
and pathogenic characteristics of these mycobacteria suggests differences in the
modes of transmission and pathogenesis, though no singular mechanism for either
characteristic has been definitively described for any of these mycobacteria.
Indeed, BU is rapidly becoming the third most
prevalent mycobacterial disease, with an impact
soon to surpass that of leprosy (6). Although it
was first documented in Australia in 1947 (7), the
disease was named after the Buruli District of
Uganda (8) after an investigation of superficial,
ulcerative lesions in Ugandan children. At the
time, the disease was sporadically reported
throughout Central and West Africa and
Australia. In the past decade, incidence of this
disease has dramatically increased, with cases
now reported in most of sub-Saharan Africa,
Mexico, Surinam, Peru, Bolivia, French Guiana,
India, sporadically throughout southern Asia,
and in Papua New Guinea (6,9). In addition,
several cases have been reported in Belgium,
Japan, Northern Ireland, and in the United
States, resulting from international travel
(6,10,11).
A retrospective investigation over a 10-year
period in the Daloa region of Côte dIvoire was
conducted to document increases in the
incidence of BU. Cases increased dramatically
over a 10-year period, with some villages
demonstrating disease rates of 16% of the
population at the end of the study (12). Current
rates are estimated at more than 22% in some of
these villages (6). Increases have also been
reported in Australia, with outbreaks of BU
during the 1990s in areas where the disease had368 Emerging Infectious Diseases Vol. 5, No. 3, MayJune 1999
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Table 2. Laboratory-confirmed cases of Mycobacterium
haemophilum in the five regions of the United States (9
states reporting), by year, 1993–1996a
No. cases (%)
Region 1993 1994 1995 1996
Northeast   0 0 0 0
Southeast 11 (79) 0 0 2 (50)
North central   1   (7) 0 0 0
South central   0 1 (25) 0 0
Mountain   2 (14) 3 (75) 3 (100) 2 (50)
Pacific   0 0 0 0
Total 14 4 3 4
aThese data are reported as part of the passive laboratory
based surveillance system using the Public Health
Laboratory Information System software developed by the
Centers for Disease Control and Prevention and the
Association of State and Territorial Public Health Laboratory
Directors.
not been previously seen (13). These data most
likely underestimate BU occurrence as there are
no reliable tools for the surveillance and
diagnosis of this disease other than clinical signs
and symptoms.
Disease caused by M. marinum was observed
in clusters of cases between 1930 and 1970, and
M. marinum was well accepted as a human
pathogen before the 1980s. In contrast,
M. haemophilum was a rarely identified
pathogen before 1974. A retrospective study
conducted in 1974 reported that, on the basis of
epidemiologic evidence, M. haemophilum was
the causative agent of a syndrome that included
mycobacterial adenitis and skin lesions that
developed in 29 immunocompetent patients (14).
In 1978, the bacterium was identified as the
cause of cutaneous ulcerating lesions in a woman
with underlying Hodgkin disease (15). Subse-
quently,  M. haemophilum has been described as
causing cutaneous lesions in persons receiving
immunosuppressive therapy after a renal
transplant (16).
The occurrence of M. marinum and
M. haemophilum in human disease is likely
underreported, as diagnosis of the diseases
caused by M. marinum and M. haemophilum is
frequently missed. Nonetheless, confirmed cases
of these diseases have been increasing, both
internationally (5) and within the United States.
A national survey involving 46 state and local
laboratory centers, representing 33 states and
the District of Columbia, was conducted from
1981 to 1983 to determine the prevalence of NTM
diseases. Fifty-three cases of NTM disease
caused by M. marinum and one case caused by
M. haemophilum were reported over the 3-year
period (17), for a national average number of
cases of 40 and 0.76 respectively, per year.
In 1993, a laboratory-based surveillance
system (18) began to assess the recent prevalence
of NTM disease in the United States. For the
Mycobacterium module, the population under
surveillance included patients in the United
States who had a specimen submitted to the state
laboratories for evaluation. It is not known what
percentage of all mycobacterial isolates this
represented. Only one isolate per person was
recorded. The geographic distribution and
number of cases of M. marinum disease (40
states reporting) and M. haemophilum disease (9
states reporting), submitted from 1993 to 1996,
are presented in Tables 1 and 2, respectively.
These data demonstrate that the number of cases
of these two diseases in the United States has
increased from the past decade, with the
estimated national average number of cases of
198 and 35 per year, respectively. In addition,
cases of M. marinum in several states over the
4-year period of this survey have increased
(Table 3) (cases of M. marinum had not been
reported in Missouri previously [17]). Elsewhere,
increases in M. marinum disease have been
reported throughout the world in temperate
climates (5).
In the United States, most cases of
M. haemophilum disease are still found in the
South; however, M. haemophilum disease has
been described in the New York City
metropolitan area (19). In addition, the number
Table 1. Laboratory-confirmed cases of Mycobacterium
marinum in the five regions of the United States (40
states reporting), by year, 1993–1996a
No. cases (%)
Region 1993 1994 1995 1996
Northeast    21 (14)    40 (22)   34 (23)   28 (18)
Southeast    58 (38)    66 (37)   41 (28)   64 (41)
North central    43 (28)    38 (21)   27 (27)   38 (24)
South central    17 (11)    17 (10)   17 (17)   14 (9)
Mountain      8 (5)    11 (6)    13 (13)     7 (5)
Pacific      5 (3)      7 (4)    15 (15)     6 (4)
Total  152  179  147  157
aThese data are reported as part of the passive laboratory-
based surveillance system using the Public Health
Laboratory Information System software developed by the
Centers for Disease Control and Prevention and the
Association of State and Territorial Public Health Laboratory
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Table 3. Laboratory-confirmed cases of Mycobacterium
marinum reported by individual states within the United
States, by year, 1993–1996a
No. cases (%)b
State 1993 1994 1995 1996
Florida 15 (9.9) 13 (7.3) 13 (8.8) 24 (15.3)
Maryland 15 (9.9) 24 (13.4) 21 (14.3) 22 (14.0)
Minnesota   6 (4.0)   4 (2.2)   6 (4.1)   8 (5.1)
Missouri   2 (1.3)   7 (3.9)   5 (3.4)   9 (5.7)
Utah   3 (1.9)   2 (1.1)   5 (3.4)   4 (2.6)
Virginia   7 (4.6) 13 (7.3) 12 (8.2) 11 (7.0)
Wisconsin   9 (5.9)   8 (4.5)   9 (6.1)   9 (5.7)
aThese data are reported as part of the passive laboratory-
based surveillance system using the Public Health
Laboratory Information System software developed by the
Centers for Disease Control and Prevention and the
Association of State and Territorial Public Health Laboratory
Directors.
bPercent (%) denotes contribution to cases reported
nationally for the year.
of cases of M. haemophilum disease in the United
States is expanding (Table 2). Thought to occur
only in immunocompromised persons (with
organ transplant patients and persons with
AIDS representing most of the patients) (20),
M. haemophilum disease was rarely reported
even in these populations before 1990. By 1994,
40 cases of M. haemophilum disease associated
with immunocompromised persons had been
reported worldwide (20). However, more re-
cently, a report by Saubolle and colleagues (19)
described 10 cases of M. haemophilum disease in
Arizona (1984 to 1994), which included cases in
two otherwise healthy children and three in
adults undergoing corticosteroid therapy for
rheumatoid arthritis or Crohn disease. Addi-
tional cases of M. haemophilum disease in
otherwise healthy children (21) and adults have
recently been observed (M.A. Saubolle, pers.
comm.). Elsewhere, M. haemophilum disease
has been reported in Australia, Canada, France,
Israel, and the United Kingdom (19).
Clinical and Histologic Features
Buruli Ulcer
M. ulcerans causes a skin disease commonly
known as BU. The incubation period can be
highly variable but is generally less than
3 months (22). The ulcers are indolent and
necrotizing (9). Systemic signs and symptoms,
such as fevers or weight loss, and bacterial
superinfection are rare (12,22). Erythema and
induration are present at the onset of infection
but subside rapidly with the beginning of
ulceration. Healing usually takes 4 to 6 months
and involves extensive scar formation. This
scarring frequently results in deformity, particu-
larly in children, in whom the result can be joint
contracture, subluxation, disuse atrophy, or
distal lymphedema. Circumferential cicatriza-
tion may lead to stunted limb growth. In one
series, 26% of patients were left with functional
disability of a limb (12). However, death from BU
is rare, and no disseminated disease has been
reported in either healthy or immunosuppressed
persons.
Histologically,  M. ulcerans produces a
circumscribed area of necrosis and (unlike most
other mycobacterial pathogens) infected tissues
that primarily contain extracellular bacilli, with
microcolonies containing large numbers of
extracellular acid-fast bacilli (AFB) in the center
of the lesions and in association with adipose
cells (Figure 1A, B). The effect of AFB at the site
of infection can be extensive during the
preulcerative phase, with few to no intracellular
AFB present (Figure 1B). The lesions are
symmetrical with associated coagulation necro-
sis of the deep dermis and panniculus. The
lesions very rarely penetrate beyond the fascia to
associate with the underlying muscle. Necrosis
occurs extensively beyond the central regions
with destruction of capillaries, larger vessels,
and adipose cells (Figure 1A) (23). The AFB
localize to the adipose tissue (Figure 1B) with
necrosis of the adipose tissues occurring at sites
distant to the location of the bacilli (Figure 1A)
and extensive AFB in all preulcerative nodules
and early lesions. The necrosis and damage of
the dermis lead to ulceration of the overlying
skin. As the ulceration spreads through the
panniculus, hypersensitivity granulomas,  most
likely stimulated by mycobacterial antigens,
develop in the dermis and other tissues
surrounding the lesions.
M. marinum Disease
M. marinum causes small ulcers or nodules,
usually on the extremities (24). The incubation
period is approximately 2 weeks to several
months (24). These lesions are minimally painful
and usually heal in 1 to 2 years without
treatment. Main symptoms include slight
tenderness and discharge from the necrotic sites.
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Figure 1. Early- (A) and late-stage (B) disease
histopathologic sections of the dermis stained for
acid-fast bacilli (AFB) from a patient with a
Mycobacterium ulcerans infection. In A, arrows
indicate necrosis of adipose tissue distant from the
location of AFB, and in B, the arrow indicates
predominance of extracellular bacilli and
microcolonies. Patients samples were obtained from
the study conducted in Côte dIvoire (12).
(Photos courtesy of National Center for Infectious Diseases,
CDC, Atlanta, Georgia.)
Figure 2 A and B. Active disease histopathologic
sections of soft tissue stained for acid-fast bacilli from
a patient with a Mycobacterium marinum infection.
In A, the arrow indicates localized necrosis, and in B,
the arrow indicates predominance of intracellular
bacilli.
(Slide courtesy of Arthur B. Abt and Leslie Parent, Penn
State Geisinger Health System and Pennsylvania State
University College of Medicine, Hershey Medical Center,
Hershey, Pennsylvania.)
spread is noted, with sporotrichoid lesions and
lymphadenitis. These lesions may result in
scarring but are less extensive than those caused
by M. ulcerans; deformity is unusual. Disease in
patients with AIDS has been reported (25), and
dissemination may occur in the immunosup-
pressed (26,27).
The bacilli are located throughout the
necrotic lesions (Figure 2A), with many bacilli
observed as singular rods within cells and
vacuoles (Figure 2B). These lesions swell
progressively as the infection ensues until
nodules are formed. Tissue necrosis usually
occurs at small sites within these nodules and is
observed only in close proximity to the AFB
(Figure 2A). Unlike lesions of M. ulcerans, the
histopathologic features of early M. marinum
lesions are similar to those of the lesions
observed in pulmonary tuberculosis (24). M.
marinum lesions generally show nonspecific371 Vol. 5, No. 3, MayJune 1999 Emerging Infectious Diseases
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Figure 3 A and B. Active disease histopathologic
sections of the epidermis stained for acid-fast bacilli
from a patient infected with Mycobacterium
haemophilum. In A and B, the arrows indicate
localized necrosis and presence of intracellular and
extracellular bacilli and microcolonies and the
presence of loose granulomas.
(Slide courtesy of Michael A. Saubolle, Good Samaritan
Regional Medical Center, Phoenix, Arizona, and Department
of Medicine, University of Arizona School of Medicine,
Tucson, Arizona.)
inflammation followed by granuloma formation
(24). Very few AFB are observed in the lesions
themselves; they are present as single or a few
bacilli without microcolonies (Figure 2A, B);
however, the organism can be cultured from the
skin lesion.
M. haemophilum Disease
M. haemophilum generally causes joint and
cutaneous infections in immunocompromised
patients and lymphadenitis and cutaneous
lesions in healthy children (19,28). In addition, a
recent report has described cutaneous lesions
arising from infection with M. haemophilum in
two healthy men with no other risk factors for
disease (19). Lesions often begin as raised,
violaceous nodules, most commonly on the
extremities (19,28). In one report, onset of
disease occurred approximately 16 months after
the onset of AIDS (28). Nodules frequently
become erythematous and ulcerated, and
recurrence of ulcers may occur in patients in
whom complete lesions were not excised (19).
Unlike M. marinum lesions, M. haemophilum
lesions are not sporotrichoid and do not appear to
localize to areas above the lymphoid tissues; they
are more frequently found above joints,
especially appearing around submandibular and
cervical joints in infections in children. Mature
lesions are often extremely painful, in contrast to
mature lesions caused by M. marinum and
M. ulcerans. The organism may also cause septic
arthritis or respiratory disease and can be
associated with systemic symptoms such as
fevers and night sweats. Disseminated disease
occurs in severely immunodeficient persons (20).
In one report, 9 of 13 immunocompromised
patients died, although death may have been due
to conditions other than M. haemophilum
infection (28).
M. haemophilum-infected skin shows minute
necrotic foci in the deep dermis surrounded by
granulocytes, lymphocytes, monocytes, fusiform
cells, and a few giant cells of the Langerhans
type (29). Large numbers of bacilli are generally
observed both extracellularly and intracellularly
as singular cells within these necrotic foci
(Figure 3A, B). Histopathologic examinations
also reveal poorly formed granulomas within the
ulcerated skin lesions (Figure 3B). Similarly,
AFB are observed inside and outside the cells
and as microcolonies within these granulomas
and in the surrounding tissue (Figure 3A, B).
Pathogenesis
One hallmark of most diseases caused by
mycobacteria is the ability of the bacilli to grow
within host cells. M. haemophilum and
M. marinum grow prolifically within fibroblast,
epithelial cells (Figures 2, 3) (30,31) and
macrophages (29,32). In contrast, M. ulcerans
primarily forms extracellular microcolonies
within necrotic tissues, is rarely found within
host cells, and disrupts macrophages and
adipose cell monolayers in vitro in lieu of
growing within these cells (33; our unpub. obs.).
Rastogi et al. (34) showed that although
M. ulcerans would infect and persist in murine
macrophages after 4 days, no intracellular
growth occurred. Others have demonstrated
that culture filtrates from M. ulcerans sup-372 Emerging Infectious Diseases Vol. 5, No. 3, MayJune 1999
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pressed phagocytosis of the bacilli and speculated
that this in vitro suppression of phagocytosis is the
reason that the bacilli are only rarely observed
within host cells in human disease (33).
The necrosis in the skin lesions of all three
mycobacterial infections suggests a secreted or
somatic cytotoxin or other necrotic bacterial
component.
Buruli Ulcer
The pre-ulcerative and early ulcer stages of
BU are characterized by a central zone of
microcolonies of AFB surrounded by a larger
zone of necrotic tissue with no evidence of host-
derived inflammatory exudates that might
contribute to cytotoxicity (35). Further, culture
filtrates from M. ulcerans produce a cytotoxic
effect on cultured fibroblasts (35). This material
simulated clinical and histopathologic changes
similar to those in BU when injected into guinea
pigs (36). An initial analysis of the culture
filtrates identified a high molecular weight
phospholipoprotein-polysaccharide complex that
retained the ability to produce a cytotoxic effect
on cell monolayers (37). Others have ascribed the
cytotoxic effect of M. ulcerans to a low molecular
weight lipid (742 daltons) in the filtrates (38).
Fractionation of the culture filtrates and
observation of the effects of each fraction on
cultured L929 fibroblast cells initially identified
a lipid as the cytotoxic component. Further
purification and analysis of this lipid did not
induce cell death, but rather arrested the
cellular growth (38).
Some suggest that the factors secreted by
M. ulcerans may also possess immunosuppres-
sive properties indirectly contributing to the
destruction of human tissue (33). Others believe
that the necrosis of tissue is due primarily to
infarction, with no contribution from cytotoxic
bacterial factors (23). Thus, the overall cytotoxic
effects demonstrated by M. ulcerans in human
disease may result from multiple factors. No
study has addressed whether cytotoxic or
immunosuppressive factors are released from
M. ulcerans during the early, active, or late
stages of infection; the mechanisms by which
such factors might act on host tissues are also not
known.
M. marinum Disease
In M. marinum infection, bacilli are capable
of invading and replicating within cultured
macrophages and epithelial cells (31). Intracellu-
lar growth of M. marinum is limited at
temperatures above 33ºC, as the bacilli do not
grow intracellularly at 37ºC. In one study,
temperature-dependent growth also correlated
with cytotoxicity of macrophage monolayers, but
no evidence of secreted toxins was noted from
supernatants of these infected tissue cultures.
The investigators suggested that intracellular
growth and a faster growth rate at 33ºC probably
caused cytotoxicity (31).
M. marinum produces skin lesions in animal
models without prior induced immunosuppres-
sion. Intravenous injection of M. marinum into
normal mice caused skin lesions similar to those
observed in humans, but no dissemination of the
organism occurred (40). Dissemination of
M. marinum was induced only when mice or
leopard frogs (Rana pipiens) were subjected to
conditions that lower the immune response, such
as lower body temperatures or treatment with
hydrocortisone (40,41). A strain adapted to an
optimal growth temperature of 37ºC in broth
culture produced immediate disseminated dis-
ease when injected into the foot pads or tail veins
of normal mice (40), demonstrating that once
temperature restriction was removed as a
barrier to growth, the bacilli quickly dissemi-
nated regardless of immune status of the mice.
M. haemophilum Disease
A putative cytotoxin from M. haemophilum
has not been reported, even though the presence
of such a toxin is suggested by histopathologic
examinations of infected tissues and in vitro
tissue culture studies (30). In particular, an
epithelial cell tissue culture model demonstrated
that  M. haemophilum induced substantial
cytotoxicity in epithelial cells at 33ºC but not at
37ºC, even though the bacilli grew extracellu-
larly in coculture with epithelial cells at 37oC
(30). Filtered supernatant from 33ºC infected
tissue cultures produced identical cytotoxic
reaction when layered onto fresh monolayers.
However, unlike from M. ulcerans, broth
medium from bacterial culture was not cytotoxic.
These studies suggest that a cytotoxin may be
produced only upon infection of epithelial cells
growing at 33ºC. Intracellular growth occurred
only during infections at 33ºC, even though
electron microscopy showed that the bacilli were
capable of invading these cells at 37ºC (30). This
temperature-specific cytotoxicity and intracellu-373 Vol. 5, No. 3, MayJune 1999 Emerging Infectious Diseases
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lar growth mimic the clinical signs of infection in
humans. The bacilli grow in cooler, superficial
regions of the body where primary tissue
destruction occurs; subsequently, the bacilli may
spread to deeper, warmer tissues of the host,
where little tissue disruption is observed and
granulomas form around the infected areas (19).
Systemic symptoms have been reported but
were not likely caused by a cytotoxin released by
the bacteria (19). Animal studies suggest that
immunosuppression leads to disseminated
M. haemophilum disease. The development of
skin lesions and dissemination by
M. haemophilum do not occur when the bacilli
are injected intravenously into healthy mice.
However, upon inoculation with M. haemophilum,
mice treated with steroids to induce immunosup-
pression develop skin lesions and disseminated
disease similar to human disease (39).
Epidemiology
Buruli Ulcer
The reservoir of M. ulcerans is unknown.
The organism has only been recovered from
lesions of humans or, in one case, a koala (42),
and there has been only one report of person-to-
person spread (9). Thus, environmental expo-
sure, either by direct inoculation or an insect
vector, is the likely route of infection.
Epidemiologic studies suggest that proximity to
water sources, such as freshwater lakes or
rivers, predisposes to disease, but specific
contact with water that might lead to
transmission of the bacteria has not been
identified. In fact, one study showed that BU was
more common during the dry season (43).
Cultures of water near BU-endemic areas have
not yielded M. ulcerans (9,12,43,44), though
testing of water samples by polymerase chain
reaction found M. ulcerans DNA (44,45). Soil also
has been considered a possible reservoir, but the
organism has not been isolated from soil
samples.
BU is primarily a disease of children, with
the highest rates found in children ages 2 to 14
years (12). Boys and girls are equally affected. In
some areas, women also have an elevated risk of
BU (12). No data are available on disease rates by
race, but the disease has been reported in all
racial groups. Although reported in persons with
HIV (46,47), no predilection for BU has been
noted in HIV-infected persons or other
immunodeficient patients, despite the substan-
tial rates of HIV in many BU-endemic areas
(9,48).
M. marinum Disease
Water is the source of infection by
M. marinum in humans (24). Recovered from
unchlorinated swimming pools and salt and
fresh water aquariums associated with cases of
disease, the organism is also a common pathogen
of fish; however, water is likely the reservoir,
and fish are a susceptible host. The organism
may be transmitted through minimal trauma or
abrasions to the skin. Person-to-person spread
has not been well documented, and no
geographic localization of the disease has been
noted (41).
The mean age of persons with M. marinum
disease is 35 to 42 years (17,24), although cases
have been reported in all age groups.
Caucasians, men, and urban residents are at
highest risk. Like BU, the disease is not
associated with immunosuppression and is rare
in AIDS patients, even though cases are common
in industrialized countries where AIDS is
prevalent (25-27).
M. haemophilum Disease
Unlike M. ulcerans and M. marinum, most
M. haemophilum infections occur in
immunocompromised patients (20). There is
scant evidence of person-to-person spread of
M. haemophilum, similar to that observed for
M. ulcerans and M. marinum infections.
M. haemophilum disease also appears to be
acquired from the environment, but the
reservoir is unknown; the organism has been
isolated only from humans with disease (20,49).
A case-control study that included cases
apparently acquired through nosocomial trans-
mission did not find common epidemiologic
elements (28). Another study considered the role
of aerosolized pentamidine in the spread of
M. haemophilum. In this study, six patients at a
cancer center contracted M. haemophilum
disease after prophylactic therapy with aero-
solized pentamidine, with two of these patients
having M. haemophilum pneumonia. The role of
this therapeutic treatment in exposure could not
be clarified either, as numerous patients
receiving this therapy did not contract
M. haemophilum, nor was the organism
recovered from the reconstituted pentamidine or374 Emerging Infectious Diseases Vol. 5, No. 3, MayJune 1999
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water used before and after nebulization (19).
Because cases have occurred in persons residing
near the ocean or large lakes, water has been
suggested as a possible reservoir (20,50). This
conjecture, however, does not explain the
increase in the number of cases observed in the
southwestern United States, particularly Ari-
zona (19).
The median age of persons with
M. haemophilum disease is 31 years, and 80%
were immunosuppressed (20). Two thirds of
cases were in men, and most were in Caucasians.
Factors Relevant to the Mode of
Transmission
Mycobacteria are widespread in the environ-
ment, particularly in aquatic reservoirs. In one
survey, more than 67% of water specimens
collected from natural, treated, and animal-
contact sources contained mycobacteria, includ-
ing  M. marinum (50). Mycobacteria also are
commonly found in soil. Wolinsky and Rynearson
(51) identified at least one Mycobacterium
species from 86% of the samples they collected
from several locations. M. haemophilum was not
recovered from any samples in this survey,
probably because the culture methods used were
not suitable for the growth of this Mycobacte-
rium.
M. ulcerans
M. ulcerans grows slowly at all temperatures
between 25ºC and 37ºC, although greater
proliferation is observed during growth at
temperatures between 30ºC and 33ºC. No colony
variants have been reported, and the bacterium
apparently has a shorter doubling time in a
medium enriched with fatty acids, a phenom-
enon consistent with bacilli in lipid-rich areas
surrounding sites of infection (6,9).
Singular lesions involving areas of the body
most susceptible to trauma (i.e., upper and lower
extremities) are frequently observed, and direct
inoculation is the most plausible mode of
transmission for M. ulcerans infection. Numer-
ous case histories document skin trauma and
abrasions preceding the onset of BU (9,12).
Others propose that an insect vector may
transmit  M. ulcerans (54), although supporting
evidence for this hypothesis has not been
reported.
M. ulcerans infections may be linked to
environmental disturbances (9,12,23,43). The
first reported cases of M. ulcerans infection
occurred 2 or 3 years after severe regional
flooding and continued intermittently until 1950
(7). In 1978, there again was severe flooding in
this area, and again approximately 2 years later,
infections occurred, first in koalas and later in
humans. Cases of BU were also observed on the
east side of the Victoria Nile in Uganda between
1962 and 64 (43); this outbreak was also likely
associated with severe flooding in the region
caused by heavy rains. As in the outbreak
observed in Australia, 2 or 3 years elapsed
between the flooding in Uganda and the first
cases in the region. In Togo, infection in children
was related to seasonal flooding of rivers in
proximity to the local village (55). Cases were
reported in one area in Liberia after swamp rice
was introduced to replace upland rice. This
introduction was associated with the construc-
tion of dams on a major river and the artificial
extension of wetlands (56). In addition, recent
cases described in Côte dIvoire occurred
primarily in association with farming activities
near the main river (12). Therefore, a common
feature of M. ulcerans disease is that infected
persons often reside near swampy areas, river
valleys, or lakes and coastal areas.
After a flood or some other environmental
disturbance, mycobacteria may be washed from
their normal habitat into draining rivers or
lakes. Given favorable circumstances, such as
relative stream stagnation, temperatures of 27ºC
to 33ºC, low salinity, low pH, and the presence of
adequate nutrients, survival and growth of the
organism may be enhanced. With the tempera-
tures that are reached in the tropics, moderate
temperatures in the surface water and in moist
silt beside lakes may be sufficient to sustain the
growth of M. ulcerans during the daytime for
most of the year (57). Moreover, M. ulcerans
could be dispersed from a water environment in
a fashion analogous to that documented for
aquatic  M. avium, where droplet aerosolization
of the organism may result in infection (50,58),
also suspected in recent BU cases in Bairnsdale,
Australia. Most of the patients infected with
M. ulcerans resided in a small region near one of
the lakes but showed no history of direct contact
with the water (57). This type of airborne
dispersal would also explain the acquisition of
BU in tree-living koalas that may be exposed to
contaminated aerosols generated in the adjacent
lake system (59). Additionally, airborne dis-375 Vol. 5, No. 3, MayJune 1999 Emerging Infectious Diseases
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persal might explain the prevalence of disease on
a geographic continuum in all countries
bordering the Gulf of Guinea in West Africa (6).
Finally, spray aerosolization of M. ulcerans in
recycled sewage water used to irrigate a golf
course has been proposed as the route of infection
for another series of cases in Australia (13).
M. marinum
Unlike that of M. ulcerans and
M. haemophilum, the etiology of M. marinum
disease is well known. Of the three, M. marinum
has the clearest association with water as the
source of the infection (60). In 1926, M. marinum
was first isolated and identified as the cause of
saltwater aquarium fish deaths (61). Tubercu-
loid skin lesions in users of a swimming pool in
1939 and 1954 and granulomatous mycobacterial
disease in freshwater fish in 1942 also were
ultimately attributed to M. marinum (62). Since
then, a variety of skin infections due to this
organism have been observed around the world,
and names such as mariners TB, aquarium
granuloma, and swimming pool granuloma
have been coined to describe the disease as well
as the source of the infection. However, when
swimming pools are properly chlorinated, this
association has all but disappeared (60).
Nevertheless, virtually any water source and
water-related activity is a potential risk,
including tending aquariums (62), fishing (63),
skin diving (62), and a number of other water-
related activities (64).
M. haemophilum
M. haemophilum is fastidious, grows slowly,
requires supplemental iron, and has a lower
incubation temperature for growth than most
other mycobacteria. This organism is usually
grown on chocolate agar, on egg-based media, or
on Middlebrook media containing 15 µg/mL to
25 µg/mL ferric ammonium citrate, 0.4%
hemoglobin, 60 µmol/L hemin, or on X-factor
(52). The temperature growth range is 25ºC to
35ºC, but the optimal incubation temperature is
32ºC (52). Because of these require-
ments,  M. haemophilum cannot be isolated by
the standard techniques used in clinical
laboratories, and its fastidiousness may account
for the lack of isolation from environmental
sources and patient specimens.
The ecology of M. haemophilum is poorly
understood, and the reservoir and modes of
transmission still need to be elucidated.
However, one study describing M. haemophilum
isolates from different patients in the same
hospital that had identical fingerprint patterns
(53) supports the possibility that the patients
were exposed to a common source, such as water.
Additional evidence that M. haemophilum grows
over a wide pH range (49) and can use chelated
iron (52), characteristics common to other
aquatic bacteria, suggests an environmental
niche. This organism survives in cold water (our
unpub. obs.) and is resistant to chlorine (50).
Several researchers have suggested using frogs
as models for the study of M. haemophilum
systemic disease, as they (or other amphibians)
have cooler body temperatures and thus could be
environmental sources for this organism (15).
Possible modes of transmission for infection
with  M. haemophilum include inhalation,
ingestion, and skin inoculation. Since most
infections occur on the skin, direct inoculation
may be most likely. However, patients were no
more likely than healthy persons from the area
to recall injuries or skin conditions before the
onset of symptoms (19), and patients generally
did not report cutaneous injuries before illness
(19). The isolation of M. haemophilum from
sputum and lung tissue suggests the possibility
of respiratory transmission; however, respira-
tory therapies, exposure to irritants, or previous
respiratory infections have rarely been associ-
ated with infection (19). Interestingly, an early
animal model demonstrated that M. haemophilum
can spread to the skin through dissemination in
the blood after intravenous inoculation, suggest-
ing bloodborne transmission (39). This study was
performed on prednisolone-treated mice chal-
lenged intravenously with M. haemophilum;
skin lesions (predominantly on the cooler regions
of the body) developed in 12 of 30 mice.
This collective evidence illustrates a defined
reservoir and mode of transmission for
M. marinum infections, and, although similar
evidence is described for M. ulcerans and
M. haemophilum, the precise mode of transmis-
sion of these infections remains undefined.
Conclusions
We have discussed the emergence of three
skin diseases and presented the pathophysi-
ologic, epidemiologic, and environmental charac-
teristics that may contribute to their emergence.376 Emerging Infectious Diseases Vol. 5, No. 3, MayJune 1999
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Disease caused by M. ulcerans and M. marinum
is primarily in immunocompetent persons, while
the emergence of M. haemophilum disease is
primarily in immunosuppressed persons. All
three mycobacteria are thought to be acquired by
inoculation during contact with contaminated
water, suggesting that changes in the environ-
ment may be contributing to their emergence.
Histologic studies demonstrate that
M. ulcerans has an apparent association with
adipose tissue, is not observed within host cells
in vivo, and does not grow intracellularly within
cultured macrophages. In contrast, M. marinum
and  M. haemophilum grow intracellularly
within cultured macrophages and epithelial cells
and have apparent associations with epithelial
tissues in vivo, suggesting that different cellular
tropisms occur between these species after the
dermis is initially infected. None of these
organisms readily cause disseminated disease in
immunocompetent humans, and this restriction
may be related to the optimal growth
temperature of these mycobacteria (tempera-
tures similar to that of the human dermis),
although all three can grow at warmer
temperatures, albeit to a lesser extent in vitro.
M. marinum colony variants that grow best at
37ºC in vitro overcome this apparent tempera-
ture restriction in vivo and disseminate in
animals, further demonstrating that while
temperature-restricted growth likely limits the
spread of disease, this restriction can be
surmounted by acquired factors. M. haemophilum
can become a disseminated disease in immuno-
suppressed persons, suggesting that the organ-
ism can also overcome temperature restrictions
in a favorable environment.
The common source of infection for these
three mycobacteria is likely water (it is the
definitive source for M. marinum). As with the
source of infection, the mode of transmission has
been clearly defined as inoculation after skin
abrasion for M. marinum, while no clear
association with skin abrasion has been
demonstrated for infection with M. ulcerans or
M. haemophilum in humans. Experimental
inoculation of all three organisms into the skin of
animals produces pathologic effects similar to
those in humans. However, epidemiologic
studies on M. ulcerans and M. haemophilum and
disease and laboratory experiments with these
two organisms in animals suggest different
modes of transmission than M. marinum,
including possible aerosol transmission with
subsequent hematogenous spread to the dermis.
Finally, comparisons of the pathogenic and
histopathologic characteristics of these three
diseases suggest differences in the levels of
virulence, mechanisms of pathogenesis, and
modes of transmission. As we learn more about
the ecology, epidemiology, and pathogenesis of
these unique mycobacteria through improve-
ments in culture techniques, diagnostic tests,
and continued laboratory research, we may be
able to identify contaminated environments
contributing to the source of these infections and
elucidate the mode of transmission. Such
information is essential if we are to develop
strategies to prevent the further emergence of
these diseases.
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